Valuation: AstraZeneca PLC

Market Cap 27TCr 23TCr 22TCr 20TCr 38TCr 25,47800Cr 38TCr 2,57500Cr 1,01100Cr 12,55100Cr 1,00300Cr 98TCr 43,14800Cr P/E 2026 *
21.6x
P/E 2027 * 19x
Enterprise Value 29TCr 25TCr 23TCr 21TCr 41TCr 27,32100Cr 41TCr 2,76100Cr 1,08400Cr 13,45900Cr 1,07600Cr 1,05200Cr 46,26900Cr EV / Sales 2026 *
4.53x
EV / Sales 2027 * 4.18x
Free-Float
96.63%
Yield 2026 *
1.94%
Yield 2027 * 2.05%

Last Transcript: AstraZeneca PLC

1 day+0.43%
1 week-8.51%
Current month-7.16%
1 month-1.73%
3 months-14.20%
6 months-4.69%
Current year-3.45%
1 week 139.26
Extreme 139.259
156.17
1 month 139.26
Extreme 139.259
157.39
Current year 137
Extreme 137.004
163
1 year 110.58
Extreme 110.576
163
3 years 104.86
Extreme 104.856
163
5 years 95
Extreme 95
163
10 years 52.7
Extreme 52.7
163
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%-8.51% - - 27TCr
-2.33%-2.09%+50.33%+162.29% 1,06000Cr
-0.82%-2.30%+62.97%+61.11% 62TCr
-0.73%-4.98%+27.22%+84.46% 44TCr
+0.33%-1.17%+27.98%+26.90% 33TCr
-0.02%-2.85%+25.27%+44.88% 28TCr
+0.66%-1.42%-29.26%-39.30% 22TCr
-0.06%-2.88%+20.98%+61.70% 20TCr
-3.72%-1.10%+13.35%+71.53% 16TCr
-0.33%-0.62%-6.25%-32.26% 14TCr
Average -0.36%-2.07%+21.40%+49.03% 38.27TCr
Weighted average by Cap. -0.23%-2.22%+34.75%+81.01%

Financials

2026 *2027 *
Net sales 6.32TCr 5.53TCr 5.1TCr 4.71TCr 8.94TCr 6,02800Cr 9.09TCr 61TCr 24TCr 2,97000Cr 24TCr 23TCr 10,20900Cr 6.68TCr 5.84TCr 5.39TCr 4.98TCr 9.44TCr 6,36800Cr 9.6TCr 64TCr 25TCr 3,13700Cr 25TCr 25TCr 10,78500Cr
Net income 1.24TCr 1.09TCr 1TCr 926.39Cr 1.76TCr 1,18600Cr 1.79TCr 12TCr 4.71TCr 58TCr 4.67TCr 4.57TCr 2,00800Cr 1.39TCr 1.22TCr 1.12TCr 1.04TCr 1.97TCr 1,32900Cr 2TCr 13TCr 5.28TCr 65TCr 5.23TCr 5.12TCr 2,25100Cr
Net Debt 1.93TCr 1.69TCr 1.56TCr 1.44TCr 2.73TCr 1,84300Cr 2.78TCr 19TCr 7.32TCr 91TCr 7.26TCr 7.1TCr 3,12100Cr 1.18TCr 1.04TCr 955.73Cr 882.71Cr 1.67TCr 1,13000Cr 1.7TCr 11TCr 4.48TCr 56TCr 4.45TCr 4.35TCr 1,91300Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change
10/26/10 CHF 139.85 +0.43%
09/26/09 CHF 139.26 -10.62%
08/26/08 CHF 155.81 -0.23%
07/26/07 CHF 156.17 +2.17%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
172.23USD
Average target price
215.33USD
Spread / Average Target
+25.02%

Quarterly revenue - Rate of surprise